Do you want to read an article? Please log in or register.
Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer
Genitourinary Cancer
Related content
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Patterns and preoperative risk factors of occult lymph node metastasis in clinical stage I lung cancer
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Yang YH, Kim HE, Park BJ, Lee JG, Kim DJ, Lee CY
doi: 10.1016/j.lungcan.2025.108461
Genitourinary Cancer
Long-term Outcomes and Prognostic Impact of Residual Cancer Burden After Intensified Neoadjuvant Therapy in High-risk Prostate Cancer
Eur Urol
Ravi P, Kwak L, Acosta AM, Rastogi S, Xie W, Abdelnaser A, Einstein DJ, Chang P, Wagner AA, McKay RR, Kibel AS, Taplin ME
doi: 10.1016/j.eururo.2025.01.015
Genitourinary Cancer
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
Prostate
Chan E, Pugh SL, Simko JP, Feng F, Shipley WU, Lukka HR, Bahary JP, Pisansky TM, Zeitzer KL, Gore E, Efstathiou JA, Rosenthal SA, Balogh AG, Lovett RD, Wong A, Dess RT, McGinnis LS, Kuettel M, DeMora L, Sandler HM
doi: 10.1002/pros.70018
Genitourinary Cancer
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
JAMA Oncol
Patel NA, Barocas DA, Lin DW, Wu X, Green D, Kensler KH, Shoag J, Al Hussein Al Awamlh B
doi: 10.1001/jamaoncol.2025.2304
Genitourinary Cancer
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study
Eur Urol
Karpinski MJ, Rahbar K, Bögemann M, Nikoukar LR, Schäfers M, Hoberück S, Miederer M, Hölscher T, Rasul S, Miszczyk M, Lanfranchi F, Bauckneht M, Pfob CH, Kind F, Goffin K, Hüsing A, Kesch C, Herrmann K, Stuschke M, Gafita A, Hüsing J, Calais J, Hofman MS, Hope TA, Miksch J, Soeterik TFW, Di Giorgio A, Farolfi A, Bjartell A, Trägårdh E, Unterrainer LM, Holzgreve A, Sheikh GT, Rauscher I, Eiber M, Hadaschik BA, Fendler WP
doi: 10.1016/j.eururo.2025.04.017
Genitourinary Cancer
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment
Eur Urol
Mazzone E, Cannoletta D, Quarta L, Chen DC, Thomson A, Barletta F, Stabile A, Moon D, Eapen R, Lawrentschuk N, Montorsi F, Siva S, Hofman MS, Chiti A, Murphy DG, Briganti A, Perera ML
doi: 10.1016/j.eururo.2025.03.003
Genitourinary Cancer
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial
Eur Urol
Vigneswaran HT, Palsdottir T, Micoli C, Tilki D, Lin D, Cooperberg M, Eggener S, Falagario UG, Möller A, Aly M, Akre O, Wiklund P, Egevad L, Grönberg H, Nordström T, Eklund M
doi: 10.1016/j.eururo.2025.10.001
Genitourinary Cancer
Are NCCN and EAU Active Surveillance Criteria Reliable in Patients With ISUP Grade-2 Intermediate-Risk Prostate Cancer? A Novel Model Integrating MRI to Predict Adverse Pathology
Prostate
Madendere S, Esen B, Karaarslan UC, Müdüroğlu M, Veznikli M, Gürses B, Vural M, Baydar DE, Demirkol MO, Kordan Y, Esen T
doi: 10.1002/pros.70073
Genitourinary Cancer
Focal radiation therapies for localized prostate cancer: a systematic review of clinical evidence and outcomes
Prostate Cancer Prostatic Dis
Le Guévelou J, Peyrottes A, Barret E, Ploussard G, Dariane C, Anract J, Olivier J, Chargari C, Zilli T
doi: 10.1038/s41391-025-01050-y